## **Core Concept**
Glucose 6-phosphatase is an enzyme crucial for glucose metabolism, specifically involved in gluconeogenesis and glycogenolysis. It catalyzes the conversion of glucose-6-phosphate to glucose, a step necessary for glucose to be released into the bloodstream. Deficiency of this enzyme leads to an inability to properly regulate blood glucose levels.

## **Why the Correct Answer is Right**
The correct answer, **Von Gierke's disease**, is associated with a deficiency of glucose 6-phosphatase. This condition is a type of glycogen storage disease (GSD Type I) characterized by the inability to convert glucose-6-phosphate into glucose for release into the bloodstream. This results in severe hypoglycemia, lactic acidosis, and hepatomegaly. The enzyme deficiency directly impacts the liver's ability to perform gluconeogenesis and glycogenolysis, leading to the clinical manifestations of the disease.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not correspond with the known associations of glucose 6-phosphatase deficiency.
- **Option B:** This option is incorrect as it does not relate to glucose 6-phosphatase deficiency.
- **Option C:** This option is incorrect because, although it's a type of glycogen storage disease, it is not the one directly associated with glucose 6-phosphatase deficiency.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that patients with Von Gierke's disease (GSD Type I) are at risk for developing complications such as gout, due to the accumulation of glucose-6-phosphate which is shunted into the pentose phosphate pathway, leading to increased production of uric acid.

## **Correct Answer:** . Von Gierke's disease